Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
32 Leser
Artikel bewerten:
(0)

Spirometers Market Worth $1,047 Million by 2023 - Exclusive Report by MarketsandMarkets

CHICAGO, Feb. 5, 2019 /PRNewswire/ --

According to the new market research report "Spirometer Market by Product (Device, Consumables, Accessories, Software), Mechanism (Flow Sensor, Peak Flow Meters), Application (COPD, Asthma), End User (Hospital, Clinical Laboratories, Home care, Industrial Settings) - Global Forecast to 2023", published by MarketsandMarkets, the Spirometers Market is expected to reach USD 1,047 million by 2023 from USD 655 million in 2018, at a CAGR of 9.8%.

MarketsandMarkets Logo

Don't miss out on business opportunities in Spirometers Market.

Growth in this market is largely driven by the rising global incidence of chronic respiratory diseases, increasing global aging population, and technological shifts in spirometer devices towards smartphone-based data connectivity.

Consumables & accessories dominated the Spirometers Market in 2018.

By product, the Spirometers Market is segmented into devices, consumables & accessories, and software. Devices are further segmented into PC-based, portable, and table-top spirometers. In 2018, the consumables & accessories accounted for the largest share of the market. The rising incidence of chronic respiratory diseases and technological shifts toward better data connectivity are driving the growth of this product segment.

Browse in-depth TOC on "Spirometers Market"

91 - Tables

28 - Figures

115 - Pages

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=18015659

COPD applications dominated the market in 2018.

Based on applications, the Spirometers Market is segmented into COPD, asthma, and other applications. In 2018, the COPD segment accounted for the largest share of the Spirometers Market. The large share of this segment can be attributed to the rising global prevalence of respiratory diseases and the increasing global aging population.

Hospitals were the largest end users in the Spirometers Market in 2018

By end user, the Spirometers Market is segmented into hospitals, clinical laboratories, home care settings, and industrial settings. The hospitals segment accounted for the largest market share in 2018 while the home care settings segment is projected to grow at the highest CAGR during the forecast period. The growing patient population and the improving healthcare infrastructure in developing countries are some of the key factors driving the growth of the hospitals segment.

Inquiry Before Buying:

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=18015659

North America commanded the largest share of the Spirometers Market in 2018.

North America commanded the largest share of the Spirometers Market. The large share of this regional segment can be attributed to the increasing incidence of chronic respiratory diseases. In addition to this, the increasing global aging population is also driving the growth of this market.

Some of the major players in this market include Hill-Rom (US), Vyaire Medical (US), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (US), Medical International Research (Italy), NDD Medical Technologies (Switzerland), Vitalograph (UK), and MidMark Corporation (US).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/spirometer-market.asp

Visit Our Website: https://www.marketsandmarkets.com

© 2019 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.